Lisa Marie Mendelson, MSN, BSN, APRN-Board Certified Adult and Gerontology
Assistant Professor, Medicine
Biography
Lisa Mendelson has been a nurse practitioner at the Boston University Amyloidosis Center since 2017. She obtained her nurse practitioner degree from MGH Institute of Health Professions in 2010 and prior to coming to BU worked in private practice cardiology and hepatology in San Mateo, CA. In addition to her clinical practice she participates as a reviewer for multiple peer reviewed journals, is an active board member for the Amyloidosis Research Consortium-Patient Discovery and has authored multiple publications with a focus on amyloidosis awareness. She is the recipient of the BU Medical Group’s 2019 clinical excellence award.
Other Positions
- Member, Amyloidosis Center, Boston University
Education
- MGH Institute of Health Professions, MSN
- MGH Institute of Health Professions, BSN
- Emmanuel College, BA
Publications
- Published on 7/5/2022
Gustine JN, Staron A, Szalat RE, Mendelson LM, Joshi T, Ruberg FL, Siddiqi O, Gopal DM, Edwards CV, Havasi A, Kaku M, Lau KHV, Berk JL, Sloan JM, Sanchorawala V. Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25-year longitudinal study. Am J Hematol. 2022 Sep; 97(9):1189-1199. PMID: 35731907.
Read at: PubMed - Published on 2/3/2022
Mendelson L, Sanchorawala V, Connors L, Joshi T, Doros G, Pogrebinsky A, Havasi A. Correlation Between 24-Hour Urine Protein and Random Urine Protein-Creatinine Ratio in Amyloid Light-Chain Amyloidosis. Kidney Med. 2022 Apr; 4(4):100427. PMID: 35342879.
Read at: PubMed - Published on 8/4/2021
Staron A, Zheng L, Doros G, Connors LH, Mendelson LM, Joshi T, Sanchorawala V. Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study. Blood Cancer J. 2021 08 04; 11(8):139. PMID: 34349108.
Read at: PubMed - Published on 7/20/2020
Schulman A, Connors LH, Weinberg J, Mendelson LM, Joshi T, Shelton AC, Sanchorawala V. Patient outcomes in light chain (AL) amyloidosis: The clock is ticking from symptoms to diagnosis. Eur J Haematol. 2020 Oct; 105(4):495-501. PMID: 32564450.
Read at: PubMed - Published on 6/6/2020
Mendelson L, Shelton A, Brauneis D, Sanchorawala V. AL Amyloidosis in Myeloma: Red Flag Symptoms. Clin Lymphoma Myeloma Leuk. 2020 11; 20(11):777-778. PMID: 32631780.
Read at: PubMed - Published on 1/1/2020
Hwa L, Fogaren T, Faller D, Stuller D, Thuenemann S, Mendelson, L . L Immunoglobulin Light-chain Amyloidosis: Clinical Presentations and Diagnostic Approach. Journal of the Advanced Practitioner in Oncology. 2020; 4(11):395-400.
Read at: Custom - Published on 7/15/2019
Staron A, Connors LH, Ruberg FL, Mendelson LM, Sanchorawala V. A new era of amyloidosis: the trends at a major US referral centre. Amyloid. 2019 Dec; 26(4):192-196. PMID: 31306033.
Read at: PubMed - Published on 7/1/2019
Hwa YL, Fogaren T, Sams A, Faller DV, Stull DM, Thuenemann S, Mendelson L. Immunoglobulin Light-Chain Amyloidosis: Clinical Presentations and Diagnostic Approach. J Adv Pract Oncol. 2019 Jul; 10(5):470-481. PMID: 33457060.
Read at: PubMed - Published on 7/21/2018
Nguyen VP, Rosenberg A, Mendelson LM, Comenzo RL, Varga C, Sanchorawala V. Outcomes of patients with AL amyloidosis and low serum free light chain levels at diagnosis. Amyloid. 2018 Sep; 25(3):156-159. PMID: 30032640.
Read at: PubMed - Published on 6/20/2018
Nguyen VP, Landau H, Quillen K, Brauneis D, Shelton AC, Mendelson L, Rahman H, Sloan JM, Sarosiek S, Sanchorawala V. Modified High-Dose Melphalan and Autologous Stem Cell Transplantation for Immunoglobulin Light Chain Amyloidosis. Biol Blood Marrow Transplant. 2018 09; 24(9):1823-1827. PMID: 29933072.
Read at: PubMed